Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$543.48 - $670.97 $59,782 - $73,806
-110 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $63,143 - $74,905
110 New
110 $68,000
Q1 2021

May 17, 2021

SELL
$446.73 - $548.2 $446 - $548
-1 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$478.3 - $607.98 $478 - $607
1 New
1 $0
Q3 2020

Nov 05, 2020

SELL
$544.75 - $658.21 $5,447 - $6,582
-10 Closed
0 $0
Q2 2020

Aug 04, 2020

SELL
$493.32 - $643.92 $4,933 - $6,439
-10 Reduced 50.0%
10 $6,000
Q1 2020

Apr 27, 2020

SELL
$336.18 - $494.43 $3,361 - $4,944
-10 Reduced 33.33%
20 $10,000
Q3 2019

Oct 30, 2019

BUY
$273.46 - $318.39 $8,203 - $9,551
30 New
30 $8,000
Q1 2019

Apr 18, 2019

SELL
$372.08 - $439.57 $14,511 - $17,143
-39 Closed
0 $0
Q4 2018

Mar 26, 2019

BUY
$335.82 - $403.04 $13,096 - $15,718
39 New
39 $14,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Liberty Wealth Management LLC Portfolio

Follow Liberty Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty Wealth Management LLC with notifications on news.